Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Roivant Sciences Ltd. (ROIV) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 SC 13D/A Roivant Sciences Ltd. reports a 55.3% stake in Immunovant, Inc.
10/20/2021 SC 13D/A Roivant Sciences Ltd. reports a 29.1% stake in Arbutus Biopharma Corporation
08/02/2021 SC 13D/A Roivant Sciences Ltd. reports a 63.8% stake in Immunovant, Inc.
03/08/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/18/2020 SC 13D/A Roivant Sciences Ltd. reports a 57.6% stake in Immunovant, Inc.
09/04/2020 SC 13D/A Roivant Sciences Ltd. reports a 54.2% stake in Immunovant, Inc.
05/14/2020 SC 13D/A Roivant Sciences Ltd. reports a 62.1% stake in Immunovant, Inc.
04/17/2020 SC 13D/A Roivant Sciences Ltd. reports a 58.2% stake in Immunovant, Inc.
02/27/2020 SC 13D/A Roivant Sciences Ltd. reports a 47.1% stake in Axovant Gene Therapies Ltd.
12/31/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/31/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/31/2019 SC 13D/A Roivant Sciences Ltd. reports a 0% stake in Urovant Sciences Ltd.
11/27/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/04/2019 SC 13D/A Roivant Sciences Ltd. reports a 75.4% stake in Urovant Sciences Ltd.
11/04/2019 SC 13D/A Roivant Sciences Ltd. reports a 45.5% stake in Myovant Sciences Ltd.
09/06/2019 SC 13D/A Roivant Sciences Ltd. reports a 58.1% stake in Axovant Gene Therapies Ltd.
09/06/2019 SC 13D/A Roivant Sciences Ltd. reports a 75.4% stake in Urovant Sciences Ltd.
09/06/2019 SC 13D/A Roivant Sciences Ltd. reports a 45.5% stake in Myovant Sciences Ltd.
07/16/2019 SC 13D/A Roivant Sciences Ltd. reports a 75.4% stake in Urovant Sciences Ltd.
07/16/2019 SC 13D/A Roivant Sciences Ltd. reports a 58.1% stake in Axovant Gene Therapies Ltd.
07/16/2019 SC 13D/A Roivant Sciences Ltd. reports a 28.2% stake in Arbutus Biopharma Corporation
07/16/2019 SC 13D/A Roivant Sciences Ltd. reports a 45.6% stake in Myovant Sciences Ltd.
03/19/2019 SC 13D/A Roivant Sciences Ltd. reports a 58.2% stake in Axovant Sciences Ltd.
12/20/2018 SC 13D/A Roivant Sciences Ltd. reports a 65.2% stake in Axovant Sciences Ltd.
04/23/2018 SC 13D/A Roivant Sciences Ltd. reports a 29.1% stake in Arbutus Biopharma Corporation
04/12/2018 SC 13D/A Roivant Sciences Ltd. reports a 29.1% stake in Arbutus Biopharma Corporation
03/16/2018 SC 13D/A Roivant Sciences Ltd. reports a 29.1% stake in Arbutus Biopharma Corporation
02/14/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/16/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/17/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/03/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/17/2016 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy